Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](RedHill Biopharma)"
Count: 20
Selected: 0
NCT04723537Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease
NCT04616924RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease
NCT04502069Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen
NCT04467840Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia
NCT04414618A Study of Opaganib in Coronavirus Disease 2019 Pneumonia
NCT04027894Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years
NCT04026984Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years
NCT03414489Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)
NCT03377179A Study of ABC294640 (Yeliva ®) Alone and in Combination With Hydroxychloroquine Sulfate in Treatment of Patients With Advanced Cholangiocarcinoma
NCT03198507ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator
NCT03009396Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease
NCT02757326ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma
NCT02757105Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
NCT02246439BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
NCT02229981Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma
NCT01980095ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
NCT01951326Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
NCT01717664Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)
NCT01488513ABC294640 in Treating Patients With Advanced Solid Tumors
NCT05954286PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19